ABL Bio Inc. (KOSDAQ: 298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
40,500
+5,400 (15.38%)
Oct 11, 2024, 9:00 AM KST

ABL Bio Revenue

ABL Bio had revenue of 8.44B KRW in the quarter ending June 30, 2024, a decrease of -1.73%. This brings the company's revenue in the last twelve months to 32.95B, down -66.11% year-over-year. In the year 2023, ABL Bio had annual revenue of 65.55B, down -2.61%.

Revenue (ttm)
32.95B
Revenue Growth
-66.11%
P/S Ratio
58.87
Revenue / Employee
323.08M
Employees
102
Market Cap
1,945.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202365.55B-1.75B-2.61%
Dec 31, 202267.30B61.97B1,162.19%
Dec 31, 20215.33B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition